M.J. Alcaraz

708 total citations
17 papers, 573 citations indexed

About

M.J. Alcaraz is a scholar working on Organic Chemistry, Pharmacology and Toxicology. According to data from OpenAlex, M.J. Alcaraz has authored 17 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 4 papers in Pharmacology and 4 papers in Toxicology. Recurrent topics in M.J. Alcaraz's work include Bioactive Compounds and Antitumor Agents (4 papers), Synthesis and biological activity (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). M.J. Alcaraz is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Synthesis and biological activity (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). M.J. Alcaraz collaborates with scholars based in Spain, Italy and Venezuela. M.J. Alcaraz's co-authors include M. Payá, Amalia Úbeda, María Carmen Terencio, María‐Jesús Sanz, Miguel Payá, Miguel A. Miranda, Sara Iborra, Marı́a Luisa Ferrándiz, Luigi Gomez‐Paloma and Antonio Randazzo and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Infectious Diseases and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M.J. Alcaraz

17 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J. Alcaraz Spain 12 187 180 124 58 55 17 573
Marie-Hélène Teiten Luxembourg 14 116 0.6× 426 2.4× 129 1.0× 90 1.6× 63 1.1× 15 859
Giridharan Periyasamy India 13 115 0.6× 236 1.3× 107 0.9× 77 1.3× 25 0.5× 22 600
Nicole Grimaud France 11 249 1.3× 125 0.7× 72 0.6× 58 1.0× 58 1.1× 31 507
Guiyang Yao China 19 355 1.9× 479 2.7× 128 1.0× 54 0.9× 44 0.8× 42 860
Yu‐Ming Hsu Taiwan 17 154 0.8× 306 1.7× 302 2.4× 107 1.8× 97 1.8× 39 772
Susana D. Lucas Portugal 18 273 1.5× 345 1.9× 114 0.9× 43 0.7× 19 0.3× 40 763
Dilip M. Mondhe India 20 185 1.0× 535 3.0× 148 1.2× 105 1.8× 43 0.8× 30 1.1k
Silvana Casati Italy 18 164 0.9× 490 2.7× 130 1.0× 89 1.5× 20 0.4× 70 936
Taha F. S. Ali Egypt 19 391 2.1× 286 1.6× 77 0.6× 39 0.7× 27 0.5× 57 859
Joseph Media United States 13 171 0.9× 259 1.4× 226 1.8× 41 0.7× 219 4.0× 26 630

Countries citing papers authored by M.J. Alcaraz

Since Specialization
Citations

This map shows the geographic impact of M.J. Alcaraz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Alcaraz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Alcaraz more than expected).

Fields of papers citing papers by M.J. Alcaraz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Alcaraz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Alcaraz. The network helps show where M.J. Alcaraz may publish in the future.

Co-authorship network of co-authors of M.J. Alcaraz

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Alcaraz. A scholar is included among the top collaborators of M.J. Alcaraz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Alcaraz. M.J. Alcaraz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bernal, Enrique, Lourdes Gimeno, M.J. Alcaraz, et al.. (2021). Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. The Journal of Infectious Diseases. 224(2). 229–240. 25 indexed citations
2.
Valdivia, Arantxa, Ignacio Torres, Dixie Huntley, et al.. (2020). Qualitative assessment of SARS‐CoV‐2‐specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay. Journal of Medical Virology. 93(2). 1141–1144. 11 indexed citations
3.
Barba‐Bon, Andrea, Ana M. Costero, Ramón Martínez‐Máñez, et al.. (2015). A Boron Dipyrromethene (BODIPY)‐Based CuII–Bipyridine Complex for Highly Selective NO Detection. Chemistry - A European Journal. 21(44). 15486–15490. 23 indexed citations
4.
Torrent, Anna, E. Montell, Josep Vergés, et al.. (2014). Effect of chondroitin sulphate and glucosamine in combination in an animal model of osteoarthritis and osteoporosis. Osteoarthritis and Cartilage. 22. S351–S351. 4 indexed citations
5.
Terencio, María Carmen, et al.. (2007). Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor. Life Sciences. 80(23). 2108–2117. 38 indexed citations
6.
Hnatyszyn, O., et al.. (2006). Flavonoids fromArtemisia copawith Anti-Inflammatory Activity. Planta Medica. 72(1). 72–74. 63 indexed citations
7.
Alcaraz, M.J., et al.. (2006). Storage stability of ketones on carbon adsorbents. Journal of Chromatography A. 1129(1). 82–87. 5 indexed citations
8.
Domingo, Santiago, et al.. (2004). Epstein-Barr virus positivity in primary vaginal lymphoma. Gynecologic Oncology. 95(3). 719–721. 7 indexed citations
10.
Alcaraz, M.J. & María Isabel Guillén. (2002). Nitric Oxide Related Therapeutic Phenomenon: A Challenging Task. Current Pharmaceutical Design. 8(3). 215–231. 22 indexed citations
11.
Soriente, Annunziata, Margherita De Rosa, Arrigo Scettri, et al.. (1999). Manoalide. Current Medicinal Chemistry. 6(5). 415–431. 53 indexed citations
12.
Sancho, Asunción, et al.. (1999). Prophylaxis of cytomegalovirus disease with intravenous ganciclovir in renal transplantation. Transplantation Proceedings. 31(6). 2337–2338. 5 indexed citations
13.
Randazzo, Antonio, et al.. (1999). Effects of Petrosaspongiolide M, a Novel Phospholipase A2 Inhibitor, on Acute and Chronic Inflammation. Journal of Pharmacology and Experimental Therapeutics. 289(1). 166–172. 78 indexed citations
14.
Terencio, María Carmen, Marı́a Luisa Ferrándiz, Inmaculada Posadas, et al.. (1998). Suppression of leukotriene B4 and tumour necrosis factor α release in acute inflammatory responses by novel prenylated hydroquinone derivatives. Naunyn-Schmiedeberg s Archives of Pharmacology. 357(5). 565–572. 24 indexed citations
15.
Úbeda, Amalia, et al.. (1997). Variabilin: A Dual Inhibitor of Human Secretory and Cytosolic Phospholipase A2 With Anti-inflammatory Activity. Journal of Pharmacology and Experimental Therapeutics. 282(1). 123–131. 48 indexed citations
16.
Sanz, María‐Jesús, Amalia Úbeda, Miguel A. Miranda, et al.. (1995). Synthesis and Pharmacological Evaluation of 2'-Hydroxychalcones and Flavones as Inhibitors of Inflammatory Mediators Generation. Journal of Medicinal Chemistry. 38(14). 2794–2797. 133 indexed citations
17.
Vergara-Jiménez, Marcela de Jesús, et al.. (1986). Anti-Inflammatory Activity of a Flavone from Sideritis leucantha. Planta Medica. 52(6). 541–541. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026